|
AngioBio Inc
rabbit anti-prox1 ![]() Rabbit Anti Prox1, supplied by AngioBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/prox1+antibody/pmc07311381-158-14-17 Average 90 stars, based on 1 article reviews
rabbit anti-prox1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Novus Biologicals
prox1 ap ![]() Prox1 Ap, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Prox1+Antibody+(5G10)+%5BAllophycocyanin%5D/pmc02794933-119-22-24 Average 94 stars, based on 1 article reviews
prox1 ap - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
R&D Systems
anti prox1 ![]() Anti Prox1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Human+Prox1+Antibody/pmc05514042-275-48-52 Average 95 stars, based on 1 article reviews
anti prox1 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
Genecopoeia
prox1 rabbit mab ![]() Prox1 Rabbit Mab, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/PROX1+Rabbit+mAb/custom%40mab-02231%4035589755 Average 95 stars, based on 1 article reviews
prox1 rabbit mab - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
R&D Systems
goat anti prox1 ![]() Goat Anti Prox1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Human+Prox1+Biotinylated+Antibody/pmc04180978-174-16-18 Average 91 stars, based on 1 article reviews
goat anti prox1 - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
Merck KGaA
anti-prox1 ![]() Anti Prox1, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/prox1+antibody/pmc08466939-3-0-4 Average 90 stars, based on 1 article reviews
anti-prox1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
3958s prox1 rabbit igg ![]() 3958s Prox1 Rabbit Igg, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Phospho-MEK1%2F2+(Ser217%2F221)+Rabbit+mAb/pm39556706-439-115-112 Average 93 stars, based on 1 article reviews
3958s prox1 rabbit igg - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Proteintech
immunoblot assay ![]() Immunoblot Assay, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/PROX1+Antibody/us12006498-191-1-9 Average 94 stars, based on 1 article reviews
immunoblot assay - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
R&D Systems
anti prox1 antibody ![]() Anti Prox1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Prox1+Antibody/pmc04900649-63-5-7 Average 91 stars, based on 1 article reviews
anti prox1 antibody - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
goat antimouse prox 1 ![]() Goat Antimouse Prox 1, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Human+Prox1+Antibody/pm38054922-38-8-20 Average 96 stars, based on 1 article reviews
goat antimouse prox 1 - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Jackson Immuno
goat anti human prox1 ![]() Goat Anti Human Prox1, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/prox+1+cell+signaling+technology+rabbit+h/Goat+Anti-Human+IgG/pmc05768392-0-2-15 Average 96 stars, based on 1 article reviews
goat anti human prox1 - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Angiogenesis
Article Title: Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis
doi: 10.1007/s10456-020-09721-1
Figure Lengend Snippet: Lymphatic hyper-branching during embryogenesis in E14.5 Prox1-CreER T2 × Mafb fl/fl embryos. a Schematic of the tamoxifen treatment in pregnant females and analysis of embryos. b Representative confocal images (maximum-intensity projections) of E14.5 embryonic back skin stained for NRP2 (green), PROX1 (red), and endomucin (EMCN) (blue). Arrowheads point to vessel junctions (branch points) within the distal sprouting area. c Number of vessel junctions and segments normalized to total vessel length and average segment length in the distal sprouting area of Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) littermates ( n = 7 animals/group). Scale bars: 100 μm. Data represent mean ± SD. Significance was determined by unpaired Student’s t-test, * p < 0.05; ** p < 0.01
Article Snippet: Primary antibodies were: rat anti-CD31 (1:200, BD Biosciences, 550274), rabbit anti-LYVE-1 (1:600, AngioBio, 11-034),
Techniques: Staining
Journal: Angiogenesis
Article Title: Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis
doi: 10.1007/s10456-020-09721-1
Figure Lengend Snippet: Lymphatic hyper-branching in Prox1-CreER T2 × Mafb fl/fl mice during postnatal development. a Schematic representation of the tamoxifen treatment schedule and analysis in newborn mice. b Representative confocal images (maximum-intensity projections) of P7 diaphragms stained for PROX1 (green) and LYVE-1 (red). c Number of vessel junctions and segments normalized to total vessel length and average segment length in the diaphragm (pleural side) of Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) littermates ( n = 7 animals/group). d Schematic representation of the tamoxifen treatment schedule and analysis in adolescent mice. e Representative confocal images (maximum-intensity projections) of P39 diaphragms stained for PROX1 (green), CD31 (red), and LYVE-1 (blue). f Number of vessel junctions and segments normalized to total vessel length and average segment length in the diaphragm (pleural side) of Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) littermates ( n = 6 animals/group). Scale bars: 100 μm. Data represent mean ± SD. Significance was determined by unpaired Student’s t -test, * p < 0.05
Article Snippet: Primary antibodies were: rat anti-CD31 (1:200, BD Biosciences, 550274), rabbit anti-LYVE-1 (1:600, AngioBio, 11-034),
Techniques: Staining
Journal: Angiogenesis
Article Title: Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis
doi: 10.1007/s10456-020-09721-1
Figure Lengend Snippet: Lymphatic deletion of MAFB is dispensable for dermal lymphatic morphology and drainage capacity in healthy adult mice. a Schematic representation of the tamoxifen treatment schedule and analysis in adult mice. b Representative confocal images (maximum-intensity projections) of split ear whole mounts of 8-week-old mice stained for LYVE-1 (green), CD31 (red), and PROX1 (blue). Number of vessel junctions normalized to total vessel length ( c ), number of vessel segments normalized to total vessel length ( d ), average segment length, ( e ) and total lymphatic vessel length ( f ) in the ear skin of Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) mice (n ≥ 8 animals/group). Scale bar: 100 μm. g Representative images showing clearance of an intradermally injected near-infrared lymphatic tracer (PEG20-IRDye800) in ears of Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) mice. h Quantification of tracer half-life in the ear skin ( n ≥ 13 animals/group). Data represent mean ± SD. Significance was determined by unpaired Student’s t-test
Article Snippet: Primary antibodies were: rat anti-CD31 (1:200, BD Biosciences, 550274), rabbit anti-LYVE-1 (1:600, AngioBio, 11-034),
Techniques: Staining, Injection
Journal: Angiogenesis
Article Title: Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis
doi: 10.1007/s10456-020-09721-1
Figure Lengend Snippet: Lymphatic MAFB deletion increases tumor-associated lymphangiogenesis. a Schematic representation of the treatment schedule with oxazolone to induce cutaneous hypersensitivity reactions in the ear skin. Mice were sensitized on day −5 and challenged by oxazolone application to the ears on days 0 and 4. b Representative immunofluorescence images of ear sections from Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) mice stained for LYVE-1 (green), MECA-32 (red), and Hoechst (blue). Scale bars: 100 μm. Quantification of the lymphatic vessel number (normalized to epidermis length, n = 8 animals/group) ( c ), percentage of the LYVE-1 stained area ( n = 8 animals/group) ( d ), and the number of MECA-32 + blood vessels (normalized to epidermis length, n = 8 animals/group) ( e ). f Schematic representation of the subcutaneous MC38 tumor model. g Representative immunofluorescence images of MC38 tumors from Mafb fl/fl (Cre −) and Prox1-CreER T2 × Mafb fl/fl (Cre +) mice stained for LYVE-1 (green), MECA-32 (red), and Hoechst (blue). Scale bars: 50 μm. Quantification of the lymphatic vessel number per field ( n ≥ 8 animals/group) ( h ), percentage of the LYVE-1 stained area ( n ≥ 8 animals/group) ( i ), and the number of MECA-32 + blood vessels per field ( n ≥ 8 animals/group) ( j ). Data represent mean ± SD. Significance was determined by unpaired Student’s t -test, * p < 0.05
Article Snippet: Primary antibodies were: rat anti-CD31 (1:200, BD Biosciences, 550274), rabbit anti-LYVE-1 (1:600, AngioBio, 11-034),
Techniques: Immunofluorescence, Staining
Journal: Cells
Article Title: Regional Variation of Gap Junctional Connections in the Mammalian Inner Retina
doi: 10.3390/cells10092396
Figure Lengend Snippet: List of key resources.
Article Snippet:
Techniques: Plasmid Preparation, Laser-Scanning Microscopy, Software
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Article Title: Deficiency of FABP7 Triggers Premature Neural Differentiation in Idiopathic Normocephalic Autism Organoids.
doi: 10.1002/advs.202406849
Figure Lengend Snippet: Figure 6. MEK2 overexpression causes autistic-like behaviors in mice, and its inhibition can rescue premature differentiation in ASD organoids. A) Schematic of AAV2/9 vectors for expressing MEK2-EGFP. B) Immunostaining images displaying GFP expressed in the hippocampus, including the dentate gyrus (DG) and CA, colabeled with the DG granule cell marker Prox1. Scale bar: 200 μm (left), 50 μm (right). C) Schematic of the open field test (Left) and histograms (Right) presenting the center zoneduration time (AAV-NC: n = 14 mice, AAV-MEK2: n = 15 mice, ns p = 0.86) and center zone entries (AAV-NC: n = 14 mice, AAV-MEK2: n = 15 mice, ns p = 0.31) of the mice in the AAV-NC and AAV-MEK2 groups. D) Schematic of the 3-chambered
Article Snippet: CTIP2 Rat IgG 1:500(IF) abcam ab18465 DCX Rabbit IgG 1:1000(IF) Cell Signaling 4604 FABP7 Rabbit IgG 1:2000(WB) 1:500(IP) Cell Signaling Technology 13347S FOXG1 Rabbit IgG 1:1000(IF) abcam ab18259 FOXP2 Rabbit IgG 1:1000(IF) abcam ab16046 GAPDH Mouse IgG 1:5000(WB) affinity T0004 GFP Chicken IgG 1:1000(IF) Millipore ab16901 GFP Rabbit IgG 1:1000(IF) Chemicon AB3080 KI67 Rabbit IgG 1:500(IF) Invitrogen 180191Z MAP4K2 Rabbit IgG 1:2000(WB) abcam ab184169 MEK1/2 Mouse IgG 1:1000(WB) Cell Signaling Technology 4694S NANOG Goat IgG 1:1000(IF) R&D Systems AF1997 NESTIN Goat IgG 1:1000(IF) Santa Cruz SC-21247 PAX6 Rabbit IgG 1:500(IF) convance PRB-278P PHH3 Rat IgG 1:1000(IF) Cell Signaling Technology 9706S PKCλ Mouse IgG 1:1000(IF) BD 610 207 p-MEK1/2 (S217/221) Rabbit IgG 1:1000(WB)
Techniques: Over Expression, Inhibition, Expressing, Immunostaining, Marker
Journal: PLoS ONE
Article Title: Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells
doi: 10.1371/journal.pone.0157126
Figure Lengend Snippet: (A-J) Embryonic tissues: bright field (A) and fluorescence (B) images of the Prox1-tdTomato embryo (E17.5). Distinct lymphatic networks shown in the embryonic skin (C-E). (E) Enlarged image of the boxed area in panel D. Lymphatic vessels in the embryonic liver (F,G) and mesentery membrane (H). Note that hepatocytes (I) and tail nerves (J) are also positive for tdTomato. (K-Y) Adult tissues: headshots of adult wild type and Prox1-tdTomato transgenic mice were taken under a bright light (K), bright and fluorescent light (L) and fluorescent light (M). Lymphatic vessels were easily detectable in various tissues such as the ear (N), eye (O,P), tail (Q), tongue (R), trachea (S), diaphragm muscle (T), bladder (U,V), intestine (W), mesentery (X) and lymph node (Y). Corneal limbal lymphatic (arrow) and Schlemm’s canal (arrowhead) of the eye were shown in two consecutive focal planes (O,P). Bilateral lymphatic collectors in the tail were marked with two arrows (Q).
Article Snippet: Prox1 staining was performed using
Techniques: Fluorescence, Membrane, Transgenic Assay
Journal: PLoS ONE
Article Title: Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells
doi: 10.1371/journal.pone.0157126
Figure Lengend Snippet: (A-H) Axillary lymphadenectomy model: Fluorescent light enables the researchers to easily locate the axillary lymph node (A-D). From a different set of mice, the left-side axillary lymph nodes were removed, while the right-side nodes were left intact. To enhance lymphatic growth in the surgical site, 9-cis RA was treated for the first 5 days after surgery. After 4 weeks, lymphatic vessels were visualized in the left vs . right side of the armpit of the mice with asterisks indicating the original locations of the lymph nodes (E,F). Images in the boxed areas (E, F) are shown in panels G and H. (I-Q) Lymph node transplantation model: the axillary lymph node in Prox1-tdTomato mice (recipient) was replaced with the matching lymph node from Prox1-EGFP mice (donor), followed by administration of 9-cis RA for 4 weeks. Panels O, P and Q are enlarged images of the boxed areas in panels K, M and N, respectively. (R-U) Tail lymphedema model: representative images of the circumcised tails at post-operational days 1 and 15 are shown (R,T). At both days, the circumcised tail skins were prepared inside-out to visualize dermal lymphatic vessels (S,U). Asterisks mark the wounded area and black dotted lines indicate the wound border. Note the numerous newly formed lymphatics invading into the healed area (S).
Article Snippet: Prox1 staining was performed using
Techniques: Transplantation Assay
Journal: PLoS ONE
Article Title: Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells
doi: 10.1371/journal.pone.0157126
Figure Lengend Snippet: (A-E) Bladder lymphangiogenesis model: Adult Prox1-tdTomato mice were i.p. injected with phosphate-buffered saline (A,C) or cyclophosphamide (B,D) at days 1 and 4. At day 9, lymphatic vessels in their bladders were visualized. Morphometric analyses revealed a significantly increase in the number of branch (marked with arrowhead), loop (arrow) and blind ends (double arrowhead) of lymphatic vessels in the CYP-treated bladder compared to the PBS-treated control (CTR) bladder (E). (F-J) Tumor implantation model: GFP-labeled tumor cells were implanted into the skin of immunodeficient athymic Prox1-tdTomato mouse, generated by crossing athymic nude mice and Prox1-tdTomato mice. Images of the GFP-labeled tumor mass (F), dermal lymphatic in the surrounding tissues (G) and their merged image (H) are shown. (I) and (J) are enlarged images of the boxed areas in panel (H) and (I), respectively. Arrows mark luminal valves.
Article Snippet: Prox1 staining was performed using
Techniques: Injection, Saline, Control, Tumor Implantation, Labeling, Generated
Journal: PLoS ONE
Article Title: Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells
doi: 10.1371/journal.pone.0157126
Figure Lengend Snippet: (A,B) Bright field (BF) and fluorescent (UV) images of the head of Prox1-tdTomato, Prox1-tdTomato/Prox1-EGFP and Prox1-EGFP lymphatic-specific reporter mice. (C-K) Expressions of tdTomato and/or EGFP proteins were visualized in the skin of embryos (EM, C-E) and new pups (P1, F-H), or in the bladder of adult (BL, I-J) of each genotype. (L-N) Prox1 whole-mount staining of the ear of tdTomato adult mouse.
Article Snippet: Prox1 staining was performed using
Techniques: Staining
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: NTHY: normal thyroid, BcPAP and TPC1: papillary thyroid carcinoma-derived cell lines, FTC-133 and CGTH-W-1: follicular thyroid carcinoma-derived cell lines. (A) Relative PROX1 mRNA expression in all cell lines. PROX1 and β -actin mRNA levels were quantified and PROX1 expression normalized against the expression of the ACTB housekeeping gene. Each bar represents the mean of triplicate measurements on three different samples for each cell line. Statistical significance was evaluated by paired Student’s t-test using the GraphPad Prism software. The corresponding P -value ( **** : P -value < 0.0001) is presented. (B) The Prox1 protein levels in the tested cell lines by Western blot. Total protein extracts from logarithmically growing cells were analyzed. ß-actin was used as a loading control. (C) Immunofluorescent labeling of the Prox1 protein (red) and its cellular localization in the analyzed cell lines. Inset: the Prox1 content and cellular localization after DAPI (blue) removal (scale bar: 10μm). All pictures were taken at a x 1000 magnification. Below: Prox1 protein content in nuclear (n) and cytoplasmic (c) fractions determined by Western blot. (D) Immunoblot analysis of Hsp90 (control for the cytoplasmic fraction) and PARP1 (control for nuclear fraction) protein expression in nuclear (n) and cytoplasmic (c) fractions isolated from the HepG2 cells.
Article Snippet: Prox1 ,
Techniques: Derivative Assay, Expressing, Software, Western Blot, Control, Labeling, Isolation
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: FTC-133 cells were treated with LY204002 (A) , the PI3K inhibitor (50μM), or with A6730 (B) , the AKT1/AKT2 inhibitor (10 μM), for 48 hours. Negative control cells were grown with DMSO instead of the inhibitors. (C) AKT and phospho-AKT expression in FTC-133 cells after silencing of PROX1 . The whole cell protein extracts were prepared and analyzed by Western blotting using a primary antibody against phospho-AKT (Ser473), AKT, or Prox1, followed by an incubation with relevant goat anti-rabbit or goat-anti mouse HRP-conjugated affinity-purified secondary antibodies. β-actin was used as a loading control.
Article Snippet: Prox1 ,
Techniques: Negative Control, Expressing, Western Blot, Incubation, Affinity Purification, Control
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: PROX1 expression in FTC-133 cells following PROX1 silencing with PROX1 -specific siRNA (A–C) or PROX1 overexpression (D–F). siNEG: negative control (cells transfected with negative siRNA). (A) and (D) PROX1 mRNA levels determined by real-time quantitative PCR (RT-qPCR). The results were normalized against ACTB transcript levels and bars represent the average PROX1 transcript levels in cells transfected with PROX1 -siRNA compared to control cells. The results represent means from five independent experiments. (B) and (E) Prox1 protein levels determined by Western blotting, and (C and F) by immunofluorescent staining. Prox1 was detected with a rabbit anti-Prox1 polyclonal antibody and the DyLight 594-conjugated purified rabbit F(ab) 2 anti-goat secondary antibodies (red), and the nuclei were stained with DAPI (blue).
Article Snippet: Prox1 ,
Techniques: Expressing, Over Expression, Negative Control, Transfection, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Control, Western Blot, Staining, Purification
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: The effect of PROX1 silencing (A) and overexpression (B) on the organization of actin cytoskeleton and cell morphology in FTC-133 cells. Following a transient transfection with si PROX1 -RNA or pIRES- PROX1 , the cells were stained with an anti-Prox1 antibody (red), with phalloidin (green) for F-actin and with DAPI (blue) for DNA. The yellow boxes depict areas which are zoomed in the bottom panel.
Article Snippet: Prox1 ,
Techniques: Over Expression, Transfection, Staining
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: The effect of PROX1 depletion on migration (A) , invasion (B) and motility (C) of FTC-133 cells, determined by chamber migration, Matrigel invasion, and wound-healing assay, respectively. Bar graphs illustrate the means ± standard deviation (SD) of the results from four independent experiments. Asterisks ( **** ) denote the P -value < 0.0001. (A) and (B) To evaluate their migration and invasive potential, the FTC-133 cells transfected with si PROX1 or control siNEG RNA were seeded in Boyden insert chambers or Matrigel Invasion Chambers with 8-μm pores. Lower chambers were filled with culture medium supplemented with 10% FBS. After 24 hours, the cells which have passed through membranes were fixed, stained, and photographed at a 40x magnification. (C) The wound closure percentage 24 hours after the scratch in monolayers of the FTC-133 cells transfected with si PROX1 or control siNEG. Representative light microscope images were taken at a 200x magnification.
Article Snippet: Prox1 ,
Techniques: Migration, Wound Healing Assay, Standard Deviation, Transfection, Control, Staining, Light Microscopy
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: The effect of PROX1 overexpression on migration (A) , invasion (B) and motility (C) of FTC-133 cells, determined by chamber migration, Matrigel invasion, and wound-healing assay, respectively. Bar graphs illustrate the means ± standard deviation (SD) of the results from four independent experiments. Asterisks denote the corresponding P -values ( **** : P -value < 0.0001; *** : P -value < 0.01) (A) and (B) To evaluate their migration and invasive potential, the FTC-133 cells transfected pIRES- PROX1 plasmid or empty pIRES plasmid were seeded in Boyden insert chambers or Matrigel Invasion Chambers with 8-μm pores. Lower chambers were filled with culture medium supplemented with 10% FBS. After 24 hours, the cells which have passed through membranes were fixed, stained, and photographed at a 40x magnification. (C) The wound closure percentage 24 hours after the scratch in monolayers of the FTC-133 cells transfected with pIRES- PROX1 or empty pIRES plasmid. Representative light microscope images were taken at a 200x magnification.
Article Snippet: Prox1 ,
Techniques: Over Expression, Migration, Wound Healing Assay, Standard Deviation, Transfection, Plasmid Preparation, Staining, Light Microscopy
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: The effect of the PROX1 knockdown (A) and overexpression (B) in FTC-133 cells on soft agar colony formation. After a transient transfection with si PROX1 or pIRES- PROX1 , the cells were seeded in 6-well culture plates containing soft agar. After two weeks, the colonies were stained and counted under a light microscope at a 100x or 200x magnification. The images show results representative of at least three independent experiments. The areas depicted by yellow boxes are zoomed in the lower panel. Lower panels show quantitative data for soft agar colonies and Matrigel spheroids formed in the two relevant assays. The PROX1 silencing significantly reduced the rate of colony formation, whereas PROX1 overexpression significantly promoted the rate of spheroid formation in FTC-133 cells. Bar graphs illustrate the means ± standard deviation (SD) from five assays, and asterisks ( ** ) indicate the P -value < 0.01.
Article Snippet: Prox1 ,
Techniques: Knockdown, Over Expression, Transfection, Staining, Light Microscopy, Standard Deviation
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: Fixed and permeabilized FTC-133 cells depleted of Prox1 or transfected with siNEG RNA were incubated overnight at 4°C with appropriate primary antibodies, followed by a one-hour room-temperature incubation with the appropriate secondary Rhodamine (TRICT)-conjugated AffiniPure F(ab’) 2 fragment goat anti-rabbit IgG and DyLight549-conjugated AffiniPure goat anti-mouse IgG antibodies (red). Images are representative confocal micrographs of FTC-133/si PROX1 cells in which F-actin was stained with phalloidin-AlexaFluor488 (green) and the nuclei (DNA) with DAPI (blue), taken at a 630x magnification. The yellow boxes depict the zoomed regions in the corresponding images.
Article Snippet: Prox1 ,
Techniques: Transfection, Incubation, Staining
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: The effect of PROX1 knockdown (A) and overexpression (B) on proliferation, cell cycle arrest, and apoptosis in FTC-133 cells. The cell proliferation was measured by the BrdU incorporation assay. Cell cycle profile was evaluated by propidium iodide staining and flow cytometry. Apoptosis rate was measured by propidium iodide and Annexin V-FITC staining followed by flow cytometry. Annexin V-FITC staining discriminates cells in early (lower right quadrant) and advanced (upper right quadrant) apoptotic states. Viable cells are double negative (lower left quadrant).
Article Snippet: Prox1 ,
Techniques: Knockdown, Over Expression, BrdU Incorporation Assay, Staining, Flow Cytometry
Journal: Oncotarget
Article Title: The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells
doi: 10.18632/oncotarget.23167
Figure Lengend Snippet: Primary and secondary antibodies used to analyse the expression of Prox1 and other proteins by western blotting and immunochistochemistry
Article Snippet: Prox1 ,
Techniques: Expressing, Western Blot, Affinity Purification, Purification, Control, Immunofluorescence